Second-Line Gemcitabine in Refractory Stage IV Non–Small-Cell Lung Cancer: A Phase II Trial
Heidi H. Gillenwater, Maureen Tynan, Susan Natoli, Michael J. Schell, Mark A. SocinskiVolume:
2
Year:
2000
Language:
english
DOI:
10.3816/clc.2000.n.026
File:
PDF, 135 KB
english, 2000